Abstracts

TNFα in Viral Control and Early Disease Progression in Patients With HIV-1 Infection

Background: Inflammatory biomarkers are associated with increased morbidity/mortality in chronic HIV-1 infection, however, their role in early HIV-1 disease is poorly understood. We hypothesized that inflammatory biomarkers in early infection are associated with the subsequent viral load set point (VLSP) and the time to reach early clinical measures of HIV-1 disease progression. Methodology: A longitudinal…

Interleukin-32: Expression Interaction With IFN and Clinical Significance in HIV-1 Infection

Background: Given the growing evidence for a role of interleukin-32 (IL-32) in the immune response to HIV-1 infection, and its interplay with type I and III interferons (IFNs), we studied the gene expression of IL-32 isoforms (α and nonα) in untreated chronically HIV-1-infected patients and in gender- and agematched healthy individuals. To further characterize both…

Monocyte Activation Markers in HIV infected Subjects: A Biomarker for HIV Immunotherapy

Background: Immune activation persists among treated HIV infected individuals and is associated with suboptimal CD4+ T cell recovery and excess morbidity and mortality. Activation of both adaptive (T cells) and innate immune systems are known to be pathogenic in treated HIV disease. This chronic inflammation may also impact outcomes of immune-modulatory and gene-modified cell therapies.…

The Clinical Impact of Viral Load Copy Years in Antiretroviral-Naïve HIV Seroconverters

Background: Ongoing viral replication may contribute to immune activation which may have deleterious effects additional to CD4 loss before antiretroviral therapy (ART) is started. A measure of the cumulative exposure to HIV replication (viral load copy years, VCY) may therefore add important prognostic information in chronic HIV infection. Methodology: Data from CASCADE, a cohort collaboration…

Telomere Length Predicts Immunological Recovery in Older HIV Patients Treated With cART

Background: Successful cART does not always recover CD4 T-cells despite the effective control of HIV-1 replication. Telomeres are DNA-protein structures essential to chromosomal stability and replication. Telomere length (TL) is probably regulated by oxidative stress. Because little is known aboutthe impact of TL on the immunorecovery we evaluated the relationship between TL and immunorecovery at…

Down-regulation of CD39/CD73 on B cells of HIV patients coincides with a disturbed Ig class switch

Background: So far, the antibody independent role of B-cells in HIV infection has not sufficiently been characterized. Recently, it has been described that down-regulation of CD73 on B cells in CVID patients correlates with a defective Ig-switch (F. Schena et al Cell Reports 2013). Here, we investigate the surface expression of two ectonucleotidases, CD39 and…

Efficacy and Safety of LPV/r Versus EFV in HIV+ Pregnant and Breast-Feeding Ugandan Women

Background: 2013 WHO ART guidelines recommend EFV-based combination ART (cART) for all pregnant women, though there are limited data on maternal/infant outcomes and alternative ART regimens. We report maternal/infant outcomes of a randomized trial comparing LPV/r to EFV-based cART in rural Uganda. Methodology: PROMOTE was an open label trial (NCT00993031) enrolling HIV+ cART-naive pregnant women…

Infant Lopinavir/r Versus 3TC to Prevent Postnatal HIV-1 Transmission: The ANRS 12174 Trial

Background: Strategies to prevent mother-to-child postnatal transmission of HIV-1 in Africa, including infant prophylaxis, have never been evaluated for the entire recommended period of breastfeeding, i.e. 12 months. Beside lamivudine, which proved safe and efficacious during 6 months for this purpose, lopinavir/ritonavir (LPV/r) is a good candidate for infant prophylaxis due to its good safety…